Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lemon extract + eucalyptus extract** is a combination product composed of extracts from the peels of *Citrus limon* (lemon) and the leaves of *Eucalyptus globulus* (eucalyptus). The combination is primarily investigated for its antimicrobial activity, with studies demonstrating **synergistic antibacterial effects against pathogens such as Streptococcus pneumoniae** and other microorganisms associated with infectious diseases and food spoilage[2][1][3]. The mechanism involves multiple phytochemicals, including *citronellal*, *1,8-cineole*, *d-limonene*, and others, believed to disrupt microbial cell membranes and interfere with microbial metabolism[1][2]. Both extracts have demonstrated properties such as **antioxidant, anti-inflammatory, analgesic, immunoregulatory, and insecticidal effects**, though the primary focus for the combination has been their synergistic antimicrobial effect[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lemon extract + eucalyptus extract.